MMIT recently held a syndicated 90-minute Webcast including the key faculty from our P&T panel, alongside key physician experts to understand the objectives outlined below:
Use the syndicated Biosimilar Webcast insights to:
Address key critical business questions surrounding new biosimilars in immunology indications by witnessing P&T and key opinion leader discussion
Understand payer strategy for management of originator and biosimilar treatments in immunology indications
Uncover differences in anticipated payer management from previous biosimilar launches in immunology